QUOTED. 17 March 2020. Marcus Vass.
The forthcoming Medicines and Medical Devices (MMD) bill will allow the UK to diverge from the EU on decisions relating to digital health. Marcus Vass, head of digital health at law firm Osborne Clarke, talked to Medtech Insight about potential ramifications.
“If people’s trust is shaken, the UK would lose the chance for greater patient engagement on digital health. But if people find their sensitive data is being misused, that would throw us backwards – and a lot could go wrong.”– Marcus Vass, head of digital health, Osborne Clarke
Click here for a free trial of Medtech Insight